Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kyntra Bio (KYNB) Shares Issued (2016 - 2024)

Historic Shares Issued for Kyntra Bio (KYNB) over the last 11 years, with Q4 2024 value amounting to $23000.0.

  • Kyntra Bio's Shares Issued changed N/A to $23000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $139000.0, marking a year-over-year increase of 1982.76%. This contributed to the annual value of $139000.0 for FY2024, which is 9971.29% down from last year.
  • Latest data reveals that Kyntra Bio reported Shares Issued of $23000.0 as of Q4 2024.
  • Over the past 5 years, Kyntra Bio's Shares Issued peaked at $30.8 million during Q1 2023, and registered a low of $23000.0 during Q4 2024.
  • Over the past 5 years, Kyntra Bio's median Shares Issued value was $4.1 million (recorded in 2021), while the average stood at $6.5 million.
  • Its Shares Issued has fluctuated over the past 5 years, first skyrocketed by 1670327.87% in 2023, then plummeted by 9934.3% in 2024.
  • Quarter analysis of 5 years shows Kyntra Bio's Shares Issued stood at $11.6 million in 2020, then tumbled by 92.76% to $838000.0 in 2021, then surged by 42.6% to $1.2 million in 2022, then skyrocketed by 1377.57% to $17.7 million in 2023, then crashed by 99.87% to $23000.0 in 2024.
  • Its last three reported values are $23000.0 in Q4 2024, $116000.0 for Q2 2024, and $17.7 million during Q2 2023.